Dix ans de cartographie de l'expression des gènes dans les tissus

Ten years have passed since the introduction of spatial transcriptomics, a groundbreaking technique that allows scientists to map gene expression within tissues while maintaining high spatial resolution. The method was first described in a landmark study published in Science in 2016 by a team led by Patrik Ståhl. Since then, the field has evolved rapidly, driven by collaborations between academic institutions and biotechnology companies. These efforts have deepened our understanding of both normal biological processes and diseases, offering new insights into how gene activity varies across different regions of tissues. In the past decade, spatial transcriptomics has become a cornerstone of modern biomedical research. Initially developed to overcome limitations in traditional bulk RNA sequencing, which averages gene expression across many cells, the technology enables the analysis of individual cells within their native microenvironment. This capability has proven invaluable in studying complex systems such as the brain, immune system, and cancerous tumors, where cellular interactions play a critical role in health and disease. Researchers have used the approach to identify previously unknown cell types, track developmental pathways, and uncover spatial patterns of gene regulation that correlate with specific physiological functions or pathological conditions. The development of spatial transcriptomics has been accompanied by advances in computational tools and hardware. Early platforms required specialized equipment and were limited in throughput, but recent innovations have made the process more accessible and scalable. For instance, some newer methods allow for whole-slide imaging combined with RNA detection, enabling comprehensive profiling of large tissue samples. These improvements have facilitated the creation of detailed “cell atlases,” which serve as reference maps for understanding the diversity and organization of cells within the human body. Such resources are increasingly being integrated into clinical settings, supporting personalized medicine and drug discovery initiatives. Collaboration between academia and industry has played a key role in accelerating progress. Academic labs have contributed foundational research, including algorithmic developments and validation studies, while biotech firms have focused on commercializing the technology and making it available to broader scientific communities. This synergy has led to the emergence of several platforms tailored for different applications, ranging from basic research to diagnostic testing. In particular, the ability to visualize gene expression alongside histological features has enhanced the accuracy of diagnoses and improved the design of targeted therapies. Despite these advancements, challenges remain. Spatial transcriptomics still faces technical hurdles, such as variability in data quality and the need for standardized protocols. Additionally, ethical considerations surrounding the use of patient-derived tissues and the interpretation of genetic data continue to be debated. Nevertheless, the field has demonstrated resilience, with ongoing efforts aimed at refining methodologies and expanding the scope of applications. Researchers are also exploring ways to integrate spatial transcriptomics with other omics approaches, such as proteomics and metabolomics, to gain a more holistic view of biological systems. Looking ahead, the next phase of spatial transcriptomics will likely involve greater integration with artificial intelligence and machine learning. These tools could help automate data analysis, identify subtle patterns, and predict functional outcomes based on spatial gene expression profiles. Furthermore, as the cost of sequencing continues to decline, the technology is expected to become more widely adopted, potentially transforming fields such as neuroscience, immunology, and oncology. With continued investment and interdisciplinary collaboration, the promise of spatial transcriptomics, offering unprecedented insight into the spatial dynamics of life, remains firmly on the horizon.